Zoetis (NYSE:ZTS) is scheduled to be releasing its earnings data before the market opens on Thursday, February 15th. Analysts expect Zoetis to post earnings of $0.66 per share for the quarter.
Shares of Zoetis (NYSE:ZTS) opened at $73.19 on Tuesday. The company has a current ratio of 2.80, a quick ratio of 1.95 and a debt-to-equity ratio of 2.45. The company has a market cap of $35,660.00, a P/E ratio of 38.52, a P/E/G ratio of 1.60 and a beta of 1.07. Zoetis has a fifty-two week low of $52.00 and a fifty-two week high of $80.13.
The business also recently declared a quarterly dividend, which will be paid on Thursday, March 1st. Investors of record on Friday, January 19th will be issued a dividend of $0.126 per share. This is a boost from Zoetis’s previous quarterly dividend of $0.11. This represents a $0.50 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Thursday, January 18th. Zoetis’s dividend payout ratio (DPR) is currently 26.32%.
Several research firms recently commented on ZTS. Piper Jaffray Companies restated a “buy” rating and set a $86.00 price target on shares of Zoetis in a report on Thursday, January 18th. BMO Capital Markets set a $78.00 price target on shares of Zoetis and gave the stock a “hold” rating in a report on Monday, January 22nd. Jefferies Group restated a “buy” rating and set a $89.00 price target on shares of Zoetis in a report on Tuesday, January 16th. Zacks Investment Research cut shares of Zoetis from a “hold” rating to a “sell” rating and set a $83.00 price target for the company. in a report on Saturday, January 13th. Finally, Cantor Fitzgerald set a $85.00 price target on shares of Zoetis and gave the stock a “buy” rating in a report on Thursday, January 11th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and fourteen have assigned a buy rating to the stock. Zoetis currently has an average rating of “Buy” and an average price target of $73.72.
COPYRIGHT VIOLATION WARNING: This piece of content was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this piece of content on another website, it was copied illegally and republished in violation of United States & international copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/13/zoetis-zts-set-to-announce-earnings-on-thursday.html.
Zoetis Company Profile
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.